作者：
Stephen J,Schuster [1]
;
Constantine S,Tam [2]
;
Peter,Borchmann [3]
;
Nina,Worel [4]
;
Joseph P,McGuirk [5]
;
Harald,Holte [6]
;
Edmund K,Waller [7]
;
Samantha,Jaglowski [8]
;
Michael R,Bishop [9]
;
Lloyd E,Damon [10]
;
Stephen Ronan,Foley [11]
;
Jason R,Westin [12]
;
Isabelle,Fleury [13]
;
P Joy,Ho [14]
;
Stephan,Mielke [15]
;
Takanori,Teshima [16]
;
Murali,Janakiram [17]
;
Jing-Mei,Hsu [18]
;
Koji,Izutsu [19]
;
Marie José,Kersten [20]
;
Monalisa,Ghosh [21]
;
Nina,Wagner-Johnston [22]
;
Koji,Kato [23]
;
Paolo,Corradini [24]
;
Marcela,Martinez-Prieto [25]
;
Xia,Han [25]
;
Ranjan,Tiwari [26]
;
Gilles,Salles [27]
;
Richard T,Maziarz [28]
作者单位：
Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: stephen.schuster@pennmedicine.upenn.edu.
[1]
Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia.
[2]
Clinic I for Internal Medicine, University Hospital of Cologne, Cologne, Germany.
[3]
Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
[4]
Department of Internal Medicine, The University of Kansas Health System, Kansas City, KS, USA.
[5]
Department of Oncology, Oslo University Hospital, Oslo, Norway.
[6]
Bone Marrow and Stem Cell Transplant Center, Emory University Winship Cancer Institute, Atlanta, GA, USA.
[7]
Blood and Marrow Transplant Program, James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
[8]
Hematopoietic Cellular Therapy Program, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
[9]
Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
[10]
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
[11]
Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
[12]
Department of Lymphoma and Myeloma, Maisonneuve-Rosement Hospital, University of Montreal, Montreal, QC, Canada.
[13]
Institute of Haematology, Royal Prince Alfred Hospital and University of Sydney, Camperdown, NSW, Australia.
[14]
Department of Medicine II, University of Würzburg Medical Center, Würzburg, Germany; Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Huddinge, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
[15]
Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
[16]
Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA.
[17]
Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.
[18]
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
[19]
Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
[20]
Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
[21]
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
[22]
Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
[23]
Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy.
[24]
Novartis Pharmaceuticals, East Hanover, NJ, USA.
[25]
Novartis Healthcare, Hyderabad, India.
[26]
Department of Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, France.
[27]
Center for Hematologic Malignancies, Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA.
[28]
主题词
澳大利亚(Australia);欧洲(Europe);女(雌)性(Female);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);日本(Japan);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);北美洲(North America);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);复发(Recurrence);T淋巴细胞(T-Lymphocytes);时间因素(Time Factors)
DOI
10.1016/S1470-2045(21)00375-2
PMID
34516954
发布时间
2021-11-08
换一批
换一批
